Cullinan Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.51M | Sell |
|
|||||
|
2025
Q2 | $3.05M | Sell |
|
|||||
|
2025
Q1 | $4.26M | Sell |
|
|||||
|
2024
Q4 | $4.05M | Sell |
|
|||||
|
2024
Q3 | $4.82M | Sell |
|
|||||
|
2024
Q2 | $4.38M | Sell |
|
|||||
|
2024
Q1 | $5.93M | Sell |
|
|||||
|
2023
Q4 | $5.86M | Sell |
|
|||||
|
2023
Q3 | $8.15M | Buy |
|
|||||
|
2023
Q2 | $8.59M | Sell |
|
|||||
|
2023
Q1 | $11.4M | Buy |
|
|||||
|
2022
Q4 | $9.04M | Buy |
|
|||||
|
2022
Q3 | $7.89M | Buy |
|
|||||
|
2022
Q2 | $7.64M | Sell |
|
|||||
|
2022
Q1 | $7.43M | Sell |
|
|||||
|
2021
Q4 | $17.3M | Buy |
|
|||||
|
2021
Q3 | $16.3M | Buy |
|
|||||
|
2021
Q2 | $17.9M | Buy |
|
|||||
|
2021
Q1 | $15.9M | Buy |
|
|||||
|
2020
Q4 | $15.6M | Sell |
|
|||||
|
2020
Q3 | $16M | Sell |
|
|||||
|
2020
Q2 | $16.1M | Buy |
|
|||||
|
2020
Q1 | $15.2M | Sell |
|
|||||
|
2019
Q4 | $17.7M | Buy |
|
|||||
|
2019
Q3 | $13.6M | Buy |
|
|||||
|
2019
Q2 | $8.66M | Buy |
|
|||||
|
2019
Q1 | $6.3M | Buy |
|
|||||
|
2018
Q4 | $4.01M | Sell |
|
|||||
|
2018
Q3 | $5.05M | Sell |
|
|||||
|
2018
Q2 | $4.85M | Sell |
|
|||||
|
2018
Q1 | $7.48M | Sell |
|
|||||
|
2017
Q4 | $7.46M | Sell |
|
|||||
|
2017
Q3 | $8.17M | Sell |
|
|||||
|
2017
Q2 | $7.37M | Sell |
|
|||||
|
2017
Q1 | $7.31M | Buy |
|
|||||
|
2016
Q4 | $7.65M | Buy |
|
|||||
|
2016
Q3 | $4.8M | Sell |
|
|||||
|
2016
Q2 | $43.1M | Buy |
|
|||||
|
2016
Q1 | $31.8M | Sell |
|
|||||
|
2015
Q4 | $68.8M | Buy |
|
|||||
|
2015
Q3 | $58.9M | Sell |
|
|||||
|
2015
Q2 | $88.4M | Sell |
|
|||||
|
2015
Q1 | $87.4M | Sell |
|
|||||
|
2014
Q4 | $81.8M | Buy |
|
|||||
|
2014
Q3 | $54.4M | Buy |
|
|||||
|
2014
Q2 | $3.65M | Sell |
|
|||||
|
2014
Q1 | $50M | Sell |
|
|||||
|
2013
Q4 | $54.4M | Buy |
|
|||||
|
2013
Q3 | $6.12M | Buy |
|
|||||
|
2013
Q2 | $5.21M | Buy |
|